In this issue: Jackie Manthorne Named 2017 Jack Shapiro Award Recipient, Clinical Trials, CCSN Advisory Councils, and much more!
Titled: What Is a Biosimilar?
2nd Annual Drug Pricing Policy Summit: Measuring Progress and Making Our Mark
Ottawa, ON – Jackie Manthorne, President and CEO of the Canadian Cancer Survivor Network (CCSN), has spent over twenty years giving a voice to cancer patients, survivors and caregivers. This fall, that dedication was recognised by the Canadian Cancer Action Network (CCAN), which awarded Manthorne the 2017 Jack Shapiro Lifetime Achievement Award at their AnnualRead More
Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a choice and help to drive prices down through competition, but doctors, patients and caregivers need to understand what biosimilars are, what they can do, andRead More
Title What Is a Biosimilar? The Current Biologics and Biosimilars Landscape in Canada Time Thursday, October 19 1:00pm – 2:00pm EST REGISTER NOW Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a choice andRead More
- Oct23Canadian Association for Population Therapeutics Annual Conference
Why you should attend: Opportunity to connect with leaders in government, health policy, academia, pharmaceutical industry, patient organizations, and contract research organizations. Qualify for reduced conference registration fee and travel bursary. HIGHLIGHTS OF THE PROGRAM: Sunday Oct. 22, 2017 @ 1–5PM (open to all registrants at no additional fee) Pre-Conference Workshop on Precision Health –View Event
- Oct23Patient Engagement and Outcomes: Taking it to the Next Level
The Canadian Association for Population Therapeutics Presents: Patient Engagement and Outcomes: Taking it to the Next Level. The CAPT Mission is to advance population-based research of therapeutic interventions to improve the health outcomes of Canadians by: Bringing together diverse perspectives Facilitating open exchange of ideas and collaboration, and Influencing policy and practice The CAPT VisionView Event
- Oct23International Conference on Cancer Biology and Therapeutics 2017
Cancer Therapeutics 2017 is the great platform for everybody to put forth their ideas of Cancer research. The main theme of the conference is “Integrating and Innovating the Ideas of Cancer Therapies”. So, Lets all join together and fight against Cancer.View Event
- The MATCH Study: Now Recruiting!
CKN is pleased to have partnered with Dr. Linda Carlson and her research team at the University of Calgary and the Princess Margaret Cancer Centre, in a ground-breaking new study measuring the effects of Mindfulness Meditation and Tai Chi/Qigong on quality of life for cancer survivors.Participate Now
- Thinking About Biosimilars – Patient Survey
This survey is a patient-led initiative conducted by the Canadian Organization for Rare Disorders.Participate Now
- Seeking Participants for Survey on Breast Cancer & Work
The Work Wellness Lab at Saint Mary’s University (Halifax, NS) is conducting a survey study on the work experiences of women who have been diagnosed with breast cancer. The study is aimed at all Canadian women 18 years of age and over diagnosed with breast cancer within the past 2 years and who were working at the time of diagnosis.Participate Now
- Volunteer for PROSTAID Calgary’s 2018 Symposium
Cancer is one of the world’s most pressing health care challenges. PROSTAID Calgary’s Cancer Advocacy Symposium will create an interactive and collaborative forum between Alberta politicians and policymakers, and Alberta’s cancer community. This is an opportunity to come together in a collaborative setting to discuss the most pressing issues facing Alberta’s healthcare system; to discuss best practices, challenges, and opportunities in the 21st century. Participate Now
The journey to my diagnosis with advanced stage bowel cancer was an unusual one. Six months prior to my diagnosis, our world had fallen apart. Our son Sam, who was 13 at the time, was diagnosed with advanced stage nasopharyngeal carcinoma. This type of cancer is very rare in the west for adults, let aloneRead More
Being diagnosed with acute leukemia was the most devastating and life-changing event I have ever faced. I was 35, healthy, and fit. I never drank or smoked. About a month before my diagnosis, I got really sick. I thought I had the flu. I was being stubborn and wouldn’t go to the doctor to getRead More